Podcast appearances and mentions of thomas hartung

El uso de animales en la investigación científica ha impulsado avances significativos en la comprensión de diversas enfermedades y el desarrollo de procesos quirúrgicos y nuevos fármacos. Sin embargo, grupos en pro de los derechos de los animales han cuestionado la ética detrás de este tipo de ensayos, ¿es posible prescindir de ellos? En este capítulo hablaremos sobre cómo surgen los experimentos con animales para fines científicos, en qué casos se utilizan, qué regulaciones existen sobre su uso y cuáles son las alternativas que actualmente buscan reducir este tipo de pruebas. Para este episodio entrevistamos a Thomas Hartung, profesor de la Universidad Johns Hopkins, donde lleva la cátedra de Toxicología Basada en Evidencia y dirige el Centro de Alternativas a la Experimentación con Animales (CAAT, por sus siglas en inglés), a Elena González, profesora investigadora del Institute for Obesity Research (IOR) del Tec de Monterrey, en la unidad de medicina experimental y es Presidenta del Comité Institucional para el Cuidado y Uso de Animales de Laboratorio (Cicual). Agradecemos el testimonio de la periodista de ciencia Inés Gutiérrez Jaber, quien para su tesis de licenciatura en Biología en la UNAM realizó un estudio sobre la memoria basado en modelos animales. Si te interesa informarte más sobre este tema te invitamos a leer los siguientes artículos: La empresa que hace modelos 3D de órganos humanos…que parecen reales La genómica al rescate de especies mexicanas en peligro de extinción Los tumores en chip pueden revolucionar el tratamiento personalizado contra el cáncer Encuentra más información en: tec.science.tec.mx La plataforma de divulgación del Tec de Monterrey. Y para que siempre estés al día con las últimas tendencias en investigación, suscríbete a nuestro newsletter.

80% of diseases are impacted by environment or lifestyle described as your exposome.  Thomas Hartung expects information from studying the exposome will bring benefits on par with those brought by studying the human genome.

There are around 350,000 synthetic chemicals in use today and only a small fraction have been robustly tested for their long-term effects on our health. Many of these are used in manufacturing plastics and microplastics – the production of which has doubled since 2008 and is projected to triple by 2060.  Unknowns remain, but research is suggesting pervasive exposures to these manufactured substances is shaping human health. In particular, links are being identified with a range of non-communicable diseases, including some cancer types, metabolic disorders, neurological conditions and reproductive and developmental issues.  So, what do we know about how the chemical environment is influencing our health? Could AI and other emerging technologies shed new light on the effects of synthetic substances? And what does it all mean for regulation and wider policy protecting public health?  To discuss, our Chief Executive Jennifer Dixon is joined by: Tracey Woodruff, Professor at University of California, San Francisco, and Director of the Program on Reproductive Health and the Environment (PRHE).  Thomas Hartung, Professor at Johns Hopkins University, and Director of the Centre for Alternatives to Animal Testing (CAAT).   Show notes Woodruff et al (2025). Manufactured chemicals and children's health – the need for new law.  Kleinstreuer & Hartung (2024). AI – it's the end of tox as we know it (and I feel fine).  Nihart et al (2025). Bioaccumulation of microplastics in decedent human brains.  Financial Times (2023). ‘Global sperm counts are falling. This scientist believes she knows why.'  Programme on Reproductive Health and the Environment (PRHE). Scientific principles to protect public health.  Programme on Reproductive Health and the Environment (PRHE). Toxic matters. 

In this episode of FYI, Brett Winton and Nemo Marjanovic sit down with Professor Thomas Hartung, MD-PhD, a leading expert in biomedical innovation at Johns Hopkins Bloomberg School of Public Health. They explore how human organoids—3D organ proxies—are revolutionizing drug discovery and toxicology testing by reducing reliance on animal models. Professor Hartung explains how advancements in stem cell science, microfluidics, and artificial intelligence are converging to accelerate clinical trials, increase safety, and lower costs. The conversation also delves into the ethical considerations of biological computing, where organoids may one day aid in cognition and pattern recognition tasks. Key Points From This Episode:The limitations of animal testing in preclinical drug discovery.How human organoids replicate organ functionality, improving research accuracy.The role of stem cells and microfluidics in advancing organ-on-chip technology.The impact of AI and big data in analyzing organoid testing outcomes.Examples of pharmaceutical companies adopting human-based models.Discussion on rapid vaccine development during the COVID-19 pandemic.The potential for brain organoids in studying neurological diseases like autism and Alzheimer's.Speculation on the use of organoids in biological computing and sensors.Ethical challenges surrounding the development of self-aware organoids.

+++ Plötzlicher Todesfall: SPD-Landtagsabgeordneter Thomas Hartung verstorben +++ Wegen großer Nachfrage: Künftig mehr Studienplätze für duales Lehramtsstudium +++ Sommer in Städten: Jena hat mit bestem Hitzeschutz +++

Sie kann Äpfel pflücken, Bilder und Texte generieren und sogar Erkrankungen wie etwa eine Blutvergiftung erkennen und damit sogar Leben retten. Seit Anfang des Jahres haben sich die Meldungen zu künstlicher Intelligenz überschlagen. Auch Thomas Hartung nutzt KI in seiner Forschung. An der Johns-Hopkins-Universität in Baltimore entwickelt er sogenannte Gehirn-Organoide, das sind sozusagen Gehirne im Miniaturformat, die im Labor aus menschlichen Zellgruppen gezüchtet und mittels KI trainiert werden. Geht es nach Hartung, könnten sie die Gehirnforschung reformieren und dabei helfen, Ursachen für Krankheiten wie Alzheimer und Autismus herauszufinden. Über den Stand der Forschung und künftige Einsatzgebiete sprechen wir in dieser Podcastfolge mit Thomas Hartung. **Hat Ihnen dieser Podcast gefallen?** Mit einem STANDARD-Abonnement können Sie unsere Arbeit unterstützen und mithelfen, Journalismus mit Haltung auch in Zukunft sicherzustellen. Alle Infos und Angebote gibt es hier: [abo.derstandard.at](https://abo.derstandard.at/?ref=Podcast&utm_source=derstandard&utm_medium=podcast&utm_campaign=podcast&utm_content=podcast)

#biotechnology #future #computer #neuroscience #organoid Could future computers run on human brain cells? Johns Hopkins researchers tout the promise of 'organoid intelligence,' which could one-day yield computers that are faster, more efficient, and more powerful than silicon-based computing and AI. Prof. Thomas Hartung is a professor of environmental health sciences at the Johns Hopkins Bloomberg School of Public Health and Whiting School of Engineering. For nearly two decades scientists have used tiny organoids, lab-grown tissue resembling fully grown organs, to experiment on kidneys, lungs, and other organs without resorting to human or animal testing. More recently Hartung and colleagues at Johns Hopkins have been working with brain organoids, orbs the size of a pen dot with neurons and other features that promise to sustain basic functions like learning and remembering. Prof.Hartung began to grow and assemble brain cells into functional organoids in 2012 using cells from human skin samples reprogrammed into an embryonic stem cell-like state. Each organoid contains about 50,000 cells, about the size of a fruit fly's nervous system. He now envisions building a futuristic computer with such brain organoids. Computers that run on this "biological hardware" could in the next decade begin to alleviate energy-consumption demands of supercomputing that are becoming increasingly unsustainable, by scaling up the production of brain organoids and training them with artificial intelligence, he foresees a future where biocomputers support superior computing speed, processing power, data efficiency, and storage capabilities. Organoid intelligence could also revolutionize drug testing research for neurodevelopmental disorders and neurodegeneration. https://www.linkedin.com/in/thomas-hartung-27a36516https://publichealth.jhu.edu/faculty/2308/thomas-hartunghttps://twitter.com/ToxmasHartung Watch our highest-viewed videos: 1-DR R VIJAYARAGHAVAN - PROF & PRINCIPAL INVESTIGATOR AT TIFR India's 1st Quantum Computer- https://youtu.be/ldKFbHb8nvQ 2-TATA MOTORS- DRIVING THE FUTURE OF MOBILITY IN INDIA- SHAILESH CHANDRA- MD : TATA MOTORS-https://youtu.be/M2Ey0fHmZJ0 3-MIT REPORT PREDICTS SOCIETAL COLLAPSE BY 2040 - GAYA HERRINGTON -DIR SUSTAINABILITY: KPMG- https://youtu.be/Jz29GOyVt04 4-WORLDS 1ST HUMAN HEAD TRANSPLANTATION- DR SERGIO CANAVERO - https://youtu.be/KY_rtubs6Lc 5-DR HAROLD KATCHER - CTO NUGENICS RESEARCH Breakthrough in Age Reversal- https://youtu.be/214jry8z3d4 6-Head of Artificial Intelligence-JIO - Shailesh Kumar https://youtu.be/q2yR14rkmZQ 7-STARTUP FROM INDIA AIMING FOR LEVEL 5 AUTONOMY - SANJEEV SHARMA CEO SWAAYATT ROBOTS - https://youtu.be/Wg7SqmIsSew 8-MAN BEHIND GOOGLE QUANTUM SUPREMACY - JOHN MARTINIS  - https://youtu.be/Y6ZaeNlVRsE 9-BANKING 4.0 - BRETT KING FUTURIST, BESTSELLING AUTHOR & FOUNDER MOVEN - https://youtu.be/2bxHAai0UG0 10-E-VTOL & HYPERLOOP- FUTURE OF INDIA"S MOBILITY- SATYANARAYANA CHAKRAVARTHY https://youtu.be/ZiK0EAelFYY 11-HOW NEUROMORPHIC COMPUTING WILL ACCELERATE ARTIFICIAL INTELLIGENCE - PROF SHUBHAM SAHAY- IIT KANPUR- https://youtu.be/sMjkG0jGCBs 12-INDIA'S QUANTUM COMPUTING INDUSTRY- PROF ARUN K PATI -DIRECTOR QETCI- https://youtu.be/Et98nkwiA8w Connect & Follow us at: https://in.linkedin.com/in/eddieavil https://in.linkedin.com/company/change-transform-india https://www.facebook.com/changetransformindia/ https://twitter.com/intothechange https://www.instagram.com/changetransformindia/ Listen to the Audio Podcast at: https://anchor.fm/transform-impossible https://podcasts.apple.com/us/podcast/change-i-m-possibleid1497201007?uo=4 https://open.spotify.com/show/56IZXdzH7M0OZUIZDb5mUZ https://www.breaker.audio/change-i-m-possible https://www.google.com/podcasts?feed=aHR0cHM6Ly9hbmNob3IuZm0vcy8xMjg4YzRmMC9wb2RjYXN0L3Jzcw Dont Forget to Subscribe www.youtube.com/ctipodcast

Intro to organoid intelligenceComparing brain organoids to supercomputersIs there any danger of organoids becoming consciousHow much does it take to claim an intelligent systemImpact of the work in the long run, on treatment of diseases like Alzheimer'sMy guest today is Prof. Thomas Hartung, MD, PhD. He is the former Head of the European Commission's Center for the Validation of Alternative Methods (ECVAM), Ispra, Italy, and has authored more than 560 scientific publications and received 16 different awards ranging from the German Ministry of Health to Hellenistic Society of Toxicology. Prof. Hartung is presently the Doerenkamp-Zbinden-Chair for Evidence-based Toxicology in the Department of Environmental Health and Engineering at Johns Hopkins Bloomberg School of Public Health, Baltimore, with a joint appointment at the Whiting School of Engineering. He also holds a joint appointment for Molecular Microbiology and Immunology at the Bloomberg School. In addition, he holds a joint appointment as Professor for Pharmacology and Toxicology at University of Konstanz, Germany; is Director of Centers for Alternatives to Animal Testing (CAAT, http://caat.jhsph.edu) of both universities. He is adjunct professor at Georgetown University, Washington D.C. and he is Chief Editor of Frontiers in Artificial Intelligence. These past few weeks,  image generators like DALL·E 2 and language models like ChatGPT  are grabbing headlines. But Prof. Hartung has been working on what sounds like an equally, if not more, revolutionary research, namely computers powered by human brain cells, part of a new field called “organoid intelligence.” Prof. Hartung explains the concept and the research.“Brains have an amazing capacity to store information, estimated at 2,500 (terabytes). We're reaching the physical limits of silicon computers because we cannot pack more transistors into a tiny chip.”In essence, Prof. Hartung is interested in two different things. One is in advanced cell culture, focusing mainly on the brain referred to as brain organoids, which is a really a breakthrough technology in recent years. And the second one is artificial intelligence, AI. And merging these two, brings them together to AI Augmented Intelligence. So the idea is, how far can we get by letting brain organoids for us do also some computational work..In response to my questions as to what's the most important thing he has learned about, about life, Prof. Hartung said, “It all happens between people. It is not about the next scientific paper, or the speech you give. It is about talking to others, inspiring each other and motivating each other to work for a goal. It's not something which is done when I'm writing my next article on the computer.”If you liked this podcast please tell your friends about it, subscribe to this podcast wherever you listen to podcasts and/or write a brief note on apple podcasts, check out my blogs on Psychology Today at https://www.psychologytoday.com/intl/contributors/thomas-r-verny-md

Can Medicine Move To Animal-Free Testing? Before a new drug can begin clinical trials in humans, it gets tested on animals. But things are changing. Late last year, Congress passed the FDA Modernization Act 2.0, which cleared the way for new drugs to skip animal testing. Can we expect to phase out animal testing altogether? Is it safe? And what technologies might make that possible? Guest host Flora Lichtman talks with Dr. Thomas Hartung, director of the Johns Hopkins Center for Alternatives to Animal Testing, to get a broader picture of alternatives to animal testing.   Capturing Carbon With Tasty Fungus This week, a report from the Intergovernmental Panel on Climate Change brought dire warnings about our planet's climate future and an alert that drastic action is needed—now—to avoid catastrophe. One action the report recommends involves an overhaul of our food production systems to decrease their carbon impact.   Writing in the Proceedings of the National Academy of Sciences, researchers suggest one possible way of sequestering some carbon dioxide might be cultivating certain kinds of edible mushrooms on land that has already been cultivated for agroforestry. The researchers are working with Lactarius deliciosus, commonly known as the saffron milk cap or red pine mushroom, but other species are possible as well. These mycorrhizal fungi live in a symbiotic relationship with the roots of the trees, increasing biomass and storing more carbon, while producing food on land that might have otherwise been used only for trees. In certain climates and with certain trees, these fungi can actually be a carbon-negative source of protein. However, to produce a pound of protein currently requires a lot of land and effort. The researchers are working to make forest fungal farming easier, and to expand the approach to a wider range of trees. SciFri's Charles Bergquist talks with Dr. Paul Thomas, author of that report and research director at the company Mycorrhizal Systems, a company that helps farmers grow truffles. He's also an honorary professor in the University of Stirling's Faculty of Natural Sciences in the UK.   Whiskey Distillery On The Rocks After Fungus Spreads Lincoln County, Tennessee has been overcome by an unwelcome guest: whiskey fungus. It covers everything from houses and cars to stop signs and trees, and no amount of power washing seems to make it go away. Why has whiskey fungus attached to this small town? It feeds on ethanol from the famed Jack Daniel's distillery, which is in a neighboring county. Lincoln County isn't the first place to encounter this problem. Whiskey fungus was first documented in 1872 by a French pharmacist named Antonin Baudoin. Baudoin noted how mold caused distillery walls in Cognac to blacken, a phenomenon that has since been seen near distilleries across the world. The fungus was not given a name until 2007, when it was dubbed Baudoinia compniacensis, named for Antonin Baudoin. Joining guest host Flora Lichtman is James A. Scott, PhD, professor of public health at the University of Toronto in Toronto, Ontario. Scott has studied whiskey fungus for over two decades, and gave it its scientific name.   NASA's New Science Head Sees A Bright Future Last month, NASA announced Dr. Nicola Fox as the agency's new scientific leader. Fox is taking on a critical role at NASA, shaping the agency's science priorities and overseeing roughly 100 missions, with a budget of $7.8 billion. The portfolio includes space science from astrophysics and Earth science, covering the planets in our solar system to exoplanets far beyond. Previously, she was the director of the heliophysics division at NASA, which studies the Sun and its role in the solar system. SciFri senior producer Charles Bergquist talks with Dr. Nicola Fox, associate administrator for the Science Mission Directorate for NASA, about her new position, career path, and plans for science at NASA.    

Computers powered by human brain cells may sound like science fiction, but a team of researchers in the US believe that's achieveable within our lifetime. Using organoids - which are lab-grown tissues resembling organs like the brain - scientists say they're close to creating a biocomputer which beats even artificial intelligence.  It's part of a burgeoning field of study called "organoid intelligence". Johns Hopkins Bloomberg School of Public Health professor Dr Thomas Hartung is a senior author on the study. He spoke to Corin Dann.    

Claudia talks to Thomas Hartung about animal testing in pharmacology and toxicology. They discuss how animal testing involves a weighing of values as well as some of the disruptive technologies that are providing alternatives to animal testing – including stem cell technologies and artificial intelligence.   Date Recorded: 5 October 2022 Thomas Hartung, MD PhD, is the Doerenkamp-Zbinden-Chair for Evidence-based Toxicology in the Department of Environmental Health and Engineering at Johns Hopkins Bloomberg School of Public Health, Baltimore, with a joint appointment at the Whiting School of Engineering. He also holds a joint appointment for Molecular Microbiology and Immunology at the Bloomberg School. He is adjunct affiliate professor at Georgetown University, Washington D.C.. In addition, he holds a joint appointment as Professor for Pharmacology and Toxicology at University of Konstanz, Germany; he also is Director of Centers for Alternatives to Animal Testing (CAAT) of both universities. CAAT hosts the secretariat of the Evidence-based Toxicology Collaboration and manages collaborative programs on Good Read-Across Practice, Good Cell Culture Practice, Green Toxicology, Developmental Neurotoxicity, Developmental Immunotoxicity, Microphysiological Systems and Refinement. As PI, he headed the Human Toxome project funded as an NIH Transformative Research Grant and the series of annual Microphysiological Systems World Summits starting in 2022 by 52 organizations. He is Field Chief Editor of Frontiers in Artificial Intelligence. He is the former Head of the European Commission's Center for the Validation of Alternative Methods (ECVAM), Ispra, Italy, and has authored more than 620 scientific publications with more than 41,000 citations (h-index 105). His toxicology classes on COURSERA had more than 15,000 active learners. Connect with Thomas on Twitter (@ToxmasHartung). Featured: Toxicology for the twenty-first century by Thomas HartungA Roadmap for the Development of Alternative (Non-Animal) Methods for Systemic Toxicity Testing By David Basketter et al Study Illustrates A Quicker And Less Expensive Way To Explore Gene-Plus-Environment Causes Of Autism Spectrum Disorder And Other Conditions via John Hopkins A Johns Hopkins collaboration has demonstrated that the novel coronavirus, SARS-CoV-2, can infect and replicate within a human mini-brain model via John HopkinsThe General Theory of Employment, Interest, and Money by John Maynard Keynes Animal Highlight: Rats -  Amanda talks about one of the most tested on animals in the world, rats. She discusses how rats have been used in labs and the standardization of their experiences. She contrasts that with the rich lifeworlds of rats who live freely and in multispecies communities. The Animal Turn is part of the  iROAR, an Animals Podcasting Network and can also be found on A.P.P.L.E, Twitter, and InstagramThank you to Animals in Philosophy, Politics, Law and Ethics (A.P.P.L.E) for sponsoring this podcast; the A.P.P.L.E Animals in Philosophy, Politics, Law and Ethics (A.P.P.L.E)Biosecurities Research Collective The Biosecurities and Urban Governance Research brings together scholars interested in biosecurity.

Dr. Thomas Hartung is a Professor at Johns Hopkins University and University of Konstanz in Germany, as well as the Director of the Center for Alternatives to Animal Testing. Dr. Sushant Kamath is a Senior Manager of Risk Assessment at Abbott Healthcare. In this podcast, Drs. Hartung and Kamath give a high level overview of the history and evolution of artificial intelligence (AI), different models used in AI, and also case examples of the use of AI in toxicology. We also discussed updates on the regulation of AI use in healthcare and toxicology and its ethical aspects. Last, we discussed challenges faced with AI and strategies to improve AI use. This podcast is incredibly informative, with general and high-level information about AI in toxicology—the future of AI is bright!

Chefredakteur Thomas Hartung blickt auf die vergangene Woche zurück. Während es bei den Großveranstaltern Umstrukturierungen gab, macht der ein oder andere ganz still und heimlich die Lichter aus. Wie sieht das Reisen in Zukunft aus? Gibt es Vorteile für geimpfte Gäste? Auch das war und bleibt ein Thema, das die Branche bewegt, und bald findet die ITB als virtuelle Plattform statt. Warum Reise-vor9-Leser nächste Woche schon mehr wissen als andere dazu in der Branche, verrät Thomas Hartung in dieser Podcast-Ausgabe. Der Reise vor9 Podcast jeden Freitag neu.

It’s January, and people all over the world are celebrating the end of the year 2020. It was harrowing for so many reasons, not the least of which was our year with the Coronavirus. Thousands of American families who have lost loved ones and millions lost their jobs too. But there is hope on the horizon as millions of Americans have started receiving the new vaccines. Three options have already been released and a fourth is on it’s way.The speed with which our scientific community has identified the virus and developed these vaccines is unprecedented. Never before have researchers been able to conduct thousands of tests in such a short period of time. In fact, it may be that the biggest impact over the long term will be the revolution in research science that made this unprecedented speed possible.Today’s Guest, Dr. Thomas Hartung is the Director of the Center for Alternatives to Animal Testing (CAAT), a laboratory for developmental neurotoxicity research based on genomics and metabolomics at Johns Hopkins University. Hartung has been leading a movement within the world of research to move away from animal testing and utilize new technologies that can save millions of dollars and lead to faster testing with more accurate results. I’ve asked him to join me today to share his insights on this revolution in a field that has been highly reliant on old methodologies.Don't forget to like, share and subscribe!

Dr. Thomas Hartung, is a professor at Johns Hopkins University and Director of the Center for Alternatives to Animal Testing. Dr. Hartung discusses some of his innovative contributions to the field of toxicology including developing advanced computer modeling systems using big data analyzed by artificial intelligence used to predict toxicity of novel compounds. Dr. Hartung gives a general overview of these concepts, and his perspective on the future of predictive modeling to supplement current toxicology research strategies. Dr. Hartung also discusses the potential for predictive modeling to expedite drug development decisions and challenges faced with introducing these technologies to regulated industries.

Thomas Hartung, MD, Johns Hopkins Bloomberg School of Public Health, delivers an insightful overview of his work studying toxicity testing improvements, organoids, and advancing technologies. Dr. Hartung has departmental affiliations with the Environmental Health and Engineering and Molecular Microbiology and Immunology departments at Johns Hopkins. Dr. Hartung's work is heavily focused on creating a paradigm shift in toxicity testing to improve overall public health. Dr. Hartung has been an integral part of the implementation of the 2007 NRC vision document known as, “Toxicity Testing in the 21st Century – a vision and a strategy.” Dr. Hartung discusses his background, and the road he has taken to arrive at his current place as a leading voice in the discussions concerning toxicity and animal testing. He explains that the technological opportunities have advanced significantly in the last few years. Dr. Hartung discusses ‘organ on a chip' technologies and other advanced tissue, etc. work. As he explains, this field is permanently moving. The advancement of organoids, which are small, self-organized 3D tissue cultures that are actually derived from stem cells, is changing the way research is done. The research doctor talks about the importance of toxicity testing, cellular communication and tissue technology, as well as genomics and metabolomics, discussing nutrients, types of cells, and the coming research that will certainly advance the field. Learning from current experiences, he explains that the ‘human on a chip' technologies will continue to change as more research is done. Organoids are being used to test various compounds to observe the relative toxicity, but they are utilized for other reasons as well, such as modeling diseases. As Dr. Hartung states, the future will likely bring these types of systems into all kinds of toxicity testing, and replace animal testing altogether if possible.

Thomas Hartung, publicista de Viña del Mar, 5ta región, no se sentía a gusto con lo que estaba haciendo por lo que decidió hacer un viaje por América. En Ecuador su travesía sufre un giro inesperado al rescatar a la perra callejera Popi, la embajadora de los perros abandonados del mundo. Luego, Thomas realiza el documental, que todos debiéramos ver, “Historias con Pulgas”, donde se muestra a los perros abandonados de Chile. Si te gustaría donar o contactar a Thomas Hartung lo puedes hacer en: Viajandoconpulgas en Facebook o Instagram. Sinopsis de documental Historias con Pulgas: https://www.youtube.com/watch?v=7tQX-516Ijw Agradecemos a Monica Hartung, quien fue nuestra invitada en el programa número 3, por hacer el contacto para esta entrevista.

Mónica y Thomas Hartung, y Natalia Sagredo son héroes anónimos chilenos que han salvado a animales. Ellos son parte de las inspiradoras historias que podrás conocer semanalmente. Soy Soledad Robledo, profesora, amante de los animales. Me encanta ver como más perros mestizos están siendo acogidos en hogares que los quieren, pero me siento impotente cuando conozco actos de crueldad animal. Hace un tiempo sentí que necesitaba hacer algo más por el bienestar animal. Luego, me inspiré al escuchar el maravilloso podcast “This Is Pawprint” conducido por Nancy y Harold Rhee. Soy una convencida de que cada uno de nosotros puede hacer algo para cambiar la realidad de los animales, por ejemplo, ser voluntario, donar o esterilizar. ¡Lo importante es comenzar hoy! Podcast "This Is Pawprint" http://www.thisispawprint.com/

Despite decades of intense research, we still know very little about how the human brain actually functions.

Dove si parla del convegno Jail's Bond la relazione uomo-animale in carcere, dei filmati di Leal Lega Antivivisezionista, con COSTANZA ROVIDA del CAAT Center foir alternatives to animal testing Europe e con THOMAS HARTUNG del Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Director Center for Alternatives to animal testing USA, del Convegno della Sapienza Università di Roma su Metodi Alternativi alla sperimentazione animale e scopriamo che Costanza avrebbe voluto essere un Gatto e Thomas un Uccello

Dove si parla del convegno Jail's Bond la relazione uomo-animale in carcere, dei filmati di Leal Lega Antivivisezionista, con COSTANZA ROVIDA del CAAT Center foir alternatives to animal testing Europe e con THOMAS HARTUNG del Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Director Center for Alternatives to animal testing USA, del Convegno della Sapienza Università di Roma su Metodi Alternativi alla sperimentazione animale e scopriamo che Costanza avrebbe voluto essere un Gatto e Thomas un Uccello

Dove si parla del convegno Jail's Bond la relazione uomo-animale in carcere, dei filmati di Leal Lega Antivivisezionista, con COSTANZA ROVIDA del CAAT Center foir alternatives to animal testing Europe e con THOMAS HARTUNG del Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Director Center for Alternatives to animal testing USA, del Convegno della Sapienza Università di Roma su Metodi Alternativi alla sperimentazione animale e scopriamo che Costanza avrebbe voluto essere un Gatto e Thomas un Uccello